These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 39206893)
41. MYL9 expressed in cancer-associated fibroblasts regulate the immune microenvironment of colorectal cancer and promotes tumor progression in an autocrine manner. Deng S; Cheng D; Wang J; Gu J; Xue Y; Jiang Z; Qin L; Mao F; Cao Y; Cai K J Exp Clin Cancer Res; 2023 Nov; 42(1):294. PubMed ID: 37926835 [TBL] [Abstract][Full Text] [Related]
42. Pan-Cancer Analysis of the Oncogenic and Immunological Role of Ding J; Meng Y; Han Z; Luo X; Guo X; Li Y; Liu S; Zhuang K Front Oncol; 2022; 12():811567. PubMed ID: 35651805 [TBL] [Abstract][Full Text] [Related]
43. Inflammation-driven senescence-associated secretory phenotype in cancer-associated fibroblasts enhances peritoneal dissemination. Yasuda T; Koiwa M; Yonemura A; Miyake K; Kariya R; Kubota S; Yokomizo-Nakano T; Yasuda-Yoshihara N; Uchihara T; Itoyama R; Bu L; Fu L; Arima K; Izumi D; Iwagami S; Eto K; Iwatsuki M; Baba Y; Yoshida N; Ohguchi H; Okada S; Matsusaki K; Sashida G; Takahashi A; Tan P; Baba H; Ishimoto T Cell Rep; 2021 Feb; 34(8):108779. PubMed ID: 33626356 [TBL] [Abstract][Full Text] [Related]
44. Podoplanin promotes the carcinogenicity of gastric cancer by activating ezrin and mediating the crosstalk between tumour cells and cancer-associated fibroblasts. Tian Y; Chen X; Wang X; Song Y Exp Physiol; 2023 May; 108(5):740-751. PubMed ID: 36156321 [TBL] [Abstract][Full Text] [Related]
45. Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression. Tang D; Gao J; Wang S; Ye N; Chong Y; Huang Y; Wang J; Li B; Yin W; Wang D Tumour Biol; 2016 Feb; 37(2):1889-99. PubMed ID: 26323258 [TBL] [Abstract][Full Text] [Related]
46. RBM4 regulates M1 macrophages polarization through targeting STAT1-mediated glycolysis. Huangfu N; Zheng W; Xu Z; Wang S; Wang Y; Cheng J; Li Z; Cheng K; Zhang S; Chen X; Zhu J Int Immunopharmacol; 2020 Jun; 83():106432. PubMed ID: 32248017 [TBL] [Abstract][Full Text] [Related]
47. Exosomal miRNA-34 from cancer-associated fibroblasts inhibits growth and invasion of gastric cancer cells Shi L; Wang Z; Geng X; Zhang Y; Xue Z Aging (Albany NY); 2020 May; 12(9):8549-8564. PubMed ID: 32391804 [TBL] [Abstract][Full Text] [Related]
48. Tumor microenvironment characteristics of lipid metabolism reprogramming related to ferroptosis and EndMT influencing prognosis in gastric cancer. Zhao Q; Yu H; Shi M; Wang X; Fan Z; Wang Z Int Immunopharmacol; 2024 Aug; 137():112433. PubMed ID: 38870879 [TBL] [Abstract][Full Text] [Related]
49. Exosomes-mediated transfer of LINC00691 regulates the formation of CAFs and promotes the progression of gastric cancer. Xia B; Gu X; Xu T; Yan M; Huang L; Jiang C; Li M; Zhai G; Zhang G; Wu J; Zhou Y; Sun C; Liang W BMC Cancer; 2023 Oct; 23(1):928. PubMed ID: 37784036 [TBL] [Abstract][Full Text] [Related]
50. Serine protease PRSS23 drives gastric cancer by enhancing tumor associated macrophage infiltration Qin S; Wang Z; Huang C; Huang P; Li D Front Immunol; 2022; 13():955841. PubMed ID: 36189305 [TBL] [Abstract][Full Text] [Related]
51. Elevated TUBA1A Might Indicate the Clinical Outcomes of Patients with Gastric Cancer, Being Associated with the Infiltration of Macrophages in the Tumor Immune Microenvironment. Wang D; Jiao Z; Ji Y; Zhang S J Gastrointestin Liver Dis; 2020 Dec; 29(4):509-522. PubMed ID: 33331338 [TBL] [Abstract][Full Text] [Related]
52. Over-expression of NFYB affects stromal cells reprogramming and predicts worse survival in gastric cancer patients. Lu T; Li C; Xiang C; Gong Y; Peng W; Hou F; Chen C Aging (Albany NY); 2022 Sep; 14(19):7851-7865. PubMed ID: 36152055 [TBL] [Abstract][Full Text] [Related]
53. Low expression of LncRNA-CAF attributed to the high expression of HIF1A in esophageal squamous cell carcinoma and gastric cancer patients. Bahramian S; Sahebi R; Roohinejad Z; Delshad E; Javid N; Amini A; Razavi AE; Shafiee M; Shamsabadi FT Mol Biol Rep; 2022 Feb; 49(2):895-905. PubMed ID: 35040008 [TBL] [Abstract][Full Text] [Related]
54. Fibroblast Activation Protein-α-Positive Fibroblasts Promote Gastric Cancer Progression and Resistance to Immune Checkpoint Blockade. Wen X; He X; Jiao F; Wang C; Sun Y; Ren X; Li Q Oncol Res; 2017 Apr; 25(4):629-640. PubMed ID: 27983931 [TBL] [Abstract][Full Text] [Related]
55. TRIM65 knockout inhibits the development of HCC by polarization tumor-associated macrophages towards M1 phenotype via JAK1/STAT1 signaling pathway. Jiang M; Wang D; Su N; Lou W; Chen Y; Yang H; Chen C; Xi F; Chen Y; Deng L; Tang X Int Immunopharmacol; 2024 Feb; 128():111494. PubMed ID: 38218012 [TBL] [Abstract][Full Text] [Related]
56. Exosome-mediated transfer of lncRNA HCG18 promotes M2 macrophage polarization in gastric cancer. Xin L; Wu Y; Liu C; Zeng F; Wang JL; Wu DZ; Wu JP; Yue ZQ; Gan JH; Lu H; Yuan YW; Zhou LQ Mol Immunol; 2021 Dec; 140():196-205. PubMed ID: 34735868 [TBL] [Abstract][Full Text] [Related]
57. The Cancer-Associated Fibroblasts-Related Gene COMP Is a Novel Predictor for Prognosis and Immunotherapy Efficacy and Is Correlated with M2 Macrophage Infiltration in Colon Cancer. Ma H; Qiu Q; Tan D; Chen Q; Liu Y; Chen B; Wang M Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671447 [TBL] [Abstract][Full Text] [Related]
58. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment. Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038 [TBL] [Abstract][Full Text] [Related]
59. Cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway. Chen S; Morine Y; Tokuda K; Yamada S; Saito Y; Nishi M; Ikemoto T; Shimada M Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195849 [TBL] [Abstract][Full Text] [Related]
60. Identification of a Gene Prognostic Model of Gastric Cancer Based on Analysis of Tumor Mutation Burden. Ma W; Li W; Xu L; Liu L; Xia Y; Yang L; Da M Pathol Oncol Res; 2021; 27():1609852. PubMed ID: 34566519 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]